Form 4: Yield10 Bioscience Director Acquires Shares in Lieu of Cash Compensation

Director Richard William Hamilton acquired 41,118 shares of Yield10 Bioscience in lieu of $15,625 in cash compensation for board service.

Summary

• Richard William Hamilton, a director at Yield10 Bioscience, acquired 41,118 shares of common stock on March 28, 2024.
• The shares were issued as compensation for services rendered as a member of the Board of Directors during the first quarter of 2024, in lieu of $15,625 in cash.
• Following the transaction, Hamilton directly owns 72,598 shares of Yield10 Bioscience.
• The transaction was executed under the Issuer's Director Compensation Policy.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a standard compensation practice. The director taking shares instead of cash is a mildly positive signal.

Positives

• A director's acceptance of shares in lieu of cash compensation demonstrates confidence in the company's future prospects.

Industry Context

Director compensation in the form of stock is a common practice in publicly traded companies, aligning the interests of directors with those of shareholders.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it aligns the director's interests with the company's stock performance.

Key Dates

Keywords

Yield10 Bioscience, Director Compensation, Stock Acquisition, Form 4, YTEN, Insider Transaction